The DOI matches its Crossref record; 154 of the 154 references it cites were found in a registry or an index.
Metallodrugs in Medicinal Inorganic Chemistry
Open accessAbstract
ADVERTISEMENT RETURN TO ISSUEPREVReviewNEXTMetallodrugs in Medicinal Inorganic ChemistryKatja Dralle Mjos and Chris Orvig*View Author Information Medicinal Inorganic Chemistry Group, Department of Chemistry, The University of British Columbia, 2036 Main Mall, Vancouver, British Columbia V6T 1Z1, Canada*E-mail: [email protected]Cite this: Chem. Rev. 2014, 114, 8, 4540–4563Publication Date (Web):January 23, 2014Publication History Received21 August 2013Published online23 January 2014Published inissue 23 April 2014https://doi.org/10.1021/cr400460sCopyright © 2014 American Chemical SocietyRIGHTS & PERMISSIONSACS AuthorChoiceArticle Views54643Altmetric-Citations837LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InReddit PDF (3 MB) Get e-AlertsSUBJECTS:Cancer,Cancer therapy,Ions,Metals,Pharmaceuticals Get e-Alerts
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Platinum Compounds: a New Class of Potent Antitumour Agents
ROSENBERG, B., VANCAMP, L., TROSKO, J. E., & MANSOUR, V. H. (1969) · Nature · doi:10.1038/222385a0 · Cited by 3,972
Cellular processing of platinum anticancer drugs
Wang, D., & Lippard, S. J. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1691 · Cited by 3,801
Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode
ROSENBERG, B., VAN CAMP, L., & KRIGAS, T. (1965) · Nature · doi:10.1038/205698a0 · Cited by 3,049
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
Massry, S. G., Coburn, J. W., Chertow, G. M., Hruska, K. A., Langman, C. B., Malluche, H. H., Martin, K. J., McCann, L. M., McCarthy, J. T., Moe, S. M., et al. (2003) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 2,527
Moe, S., Drüeke, T., Cunningham, J., Goodman, W., Martin, K., Olgaard, K., Ott, S., Sprague, S., Lameire, N., & Eknoyan, G. (2006) · Kidney International · doi:10.1038/sj.ki.5000414 · Cited by 1,993
Organometallic Anticancer Compounds
Gasser, G., Ott, I., & Metzler-Nolte, N. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm100020w · Cited by 1,624
The exploration of macrocycles for drug discovery — an underexploited structural class
Driggers, E. M., Hale, S. P., Lee, J., & Terrett, N. K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2590 · Cited by 1,370
FDA Approval Summary: Vorinostat for Treatment of Advanced Primary Cutaneous T-Cell Lymphoma
Mann, B. S., Johnson, J. R., Cohen, M. H., Justice, R., & Pazdur, R. (2007) · The Oncologist · doi:10.1634/theoncologist.12-10-1247 · Cited by 1,365
Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug
(1999) · Wiley eBooks · doi:10.1002/9783906390420 · Cited by 1,296
Ritchie, C. W., Bush, A. I., Mackinnon, A., Macfarlane, S., Mastwyk, M., MacGregor, L., Kiers, L., Cherny, R., Li, Q.-X., Tammer, A., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.12.1685 · Cited by 988
Hartinger, C. G., Zorbas-Seifried, S., Jakupec, M. A., Kynast, B., Zorbas, H., & Keppler, B. K. (2006) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2006.02.013 · Cited by 956
Parkinson's disease: from monogenic forms to genetic susceptibility factors
Lesage, S., & Brice, A. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp012 · Cited by 945
Mechanisms of resistance to cisplatin
Kartalou, M., & Essigmann, J. M. (2001) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(01)00141-5 · Cited by 869
Guo, Z., & Sadler, P. J. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19990601)38:11<1512::aid-anie1512>3.0.co;2-y · Cited by 834
Hartinger, C. G., Jakupec, M. A., Zorbas‐Seifried, S., Groessl, M., Egger, A., Berger, W., Zorbas, H., Dyson, P. J., & Keppler, B. K. (2008) · Chemistry & Biodiversity · doi:10.1002/cbdv.200890195 · Cited by 830
On the medicinal chemistry of gold complexes as anticancer drugs
Ott, I. (2009) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2009.02.019 · Cited by 825
Nanobio Silver: Its Interactions with Peptides and Bacteria, and Its Uses in Medicine
Eckhardt, S., Brunetto, P. S., Gagnon, J., Priebe, M., Giese, B., & Fromm, K. M. (2013) · Chemical Reviews · doi:10.1021/cr300288v · Cited by 794
In Vitro and in Vivo Evaluation of Ruthenium(II)−Arene PTA Complexes
Scolaro, C., Bergamo, A., Brescacín, L., Delfino, R., Cocchietto, M., Laurenczy, G., Geldbach, T. J., Sava, G., & Dyson, P. J. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050015d · Cited by 784
Why Does Cisplatin Reach Guanine-N7 with Competing S-Donor Ligands Available in the Cell?
Reedijk, J. (1999) · Chemical Reviews · doi:10.1021/cr980422f · Cited by 771
Consensus development conference: prophylaxis and treatment of osteoporosis.
(1987) · BMJ · doi:10.1136/bmj.295.6603.914 · Cited by 727
Lannfelt, L., Blennow, K., Zetterberg, H., Batsman, S., Ames, D., Harrison, J., Masters, C. L., Targum, S., Bush, A. I., Murdoch, R., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70167-4 · Cited by 725
Cappellini, M. D. (2006) · Blood · doi:10.1182/blood-2005-08-3430 · Cited by 717
Exploration of the medical periodic table: towards new targets
Barry, N. P. E., & Sadler, P. J. (2013) · Chemical Communications · doi:10.1039/c3cc41143e · Cited by 717
Effect of Vanadate on Elevated Blood Glucose and Depressed Cardiac Performance of Diabetic Rats
Heyliger, C. E., Tahiliani, A. G., & McNeill, J. H. (1985) · Science · doi:10.1126/science.3156405 · Cited by 711
The Practice of Medicinal Chemistry
(2003) · Elsevier eBooks · doi:10.1016/b978-0-12-744481-9.x5000-4 · Cited by 702
Phase II and Phase III attrition rates 2011–2012
Arrowsmith, J., & Miller, P. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4090 · Cited by 697
Areneruthenium complexes as anticancer agents
Süß‐Fink, G. (2009) · Dalton Transactions · doi:10.1039/b916860p · Cited by 652
Consensus development conference: prophylaxis and treatment of osteoporosis
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90512-v · Cited by 632
Mechanisms of resistance to cisplatin and carboplatin
Stewart, D. J. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.02.001 · Cited by 631
Platinum(IV) antitumour compounds: their bioinorganic chemistry
Hall, M. D., & Hambley, T. W. (2002) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(02)00026-7 · Cited by 622
Aird, R. E., Cummings, J., Ritchie, A. A., Muir, M., Morris, R. E., Chen, H., Sadler, P. J., & Jodrell, D. I. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600290 · Cited by 582
Medicinal Inorganic Chemistry: Introduction
Orvig, C., & Abrams, M. J. (1999) · Chemical Reviews · doi:10.1021/cr980419w · Cited by 532
Self-citationThe Discovery and Development of Cisplatin
Alderden, R. A., Hall, M. D., & Hambley, T. W. (2006) · Journal of Chemical Education · doi:10.1021/ed083p728 · Cited by 532
Superoxide Dismutase Mimics: Chemistry, Pharmacology, and Therapeutic Potential
Batinić-Haberle, I., Rebouças, J. S., & Spasojević, I. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2876 · Cited by 531
Malfertheiner, P., Bazzoli, F., Delchier, J.-C., Celiñski, K., Giguère, M., Rivière, M., & Mégraud, F. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60020-2 · Cited by 523
Rheumatoid Arthritis: Diagnosis and Management
Majithia, V., & Geraci, S. A. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.04.005 · Cited by 522
Vanadium treatment of type 2 diabetes: A view to the future
Thompson, K. H., Lichter, J., LeBel, C., Scaife, M. C., McNeill, J. H., & Orvig, C. (2009) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2008.12.003 · Cited by 520
Self-citation99mTc-Labeled Small Peptides as Diagnostic Radiopharmaceuticals
Liu, S., & Edwards, D. S. (1999) · Chemical Reviews · doi:10.1021/cr980436l · Cited by 511
Vanadium in diabetes: 100 years from Phase 0 to Phase I
Thompson, K. H., & Orvig, C. (2006) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2006.08.016 · Cited by 508
Self-citationHarford, C., & Sarkar, B. (1997) · Accounts of Chemical Research · doi:10.1021/ar9501535 · Cited by 508
Gold Nanoparticles: A Revival in Precious Metal Administration to Patients
Thakor, A. S., Jokerst, J., Zavaleta, C., Massoud, T. F., & Gambhir, S. S. (2011) · Nano Letters · doi:10.1021/nl202559p · Cited by 468
De Clercq, E. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1134 · Cited by 460
Radiometal-Labeled Agents (Non-Technetium) for Diagnostic Imaging
Anderson, C. J., & Welch, M. J. (1999) · Chemical Reviews · doi:10.1021/cr980451q · Cited by 455
Potential Mechanisms of Action of Lithium in Bipolar Disorder: Current Understanding
Malhi, G. S., Tanious, M., Das, P., Coulston, C. M., & Berk, M. (2013) · CNS Drugs · doi:10.1007/s40263-013-0039-0 · Cited by 453
Targeting proteins with metal complexes
Meggers, E. (2009) · Chemical Communications · doi:10.1039/b813568a · Cited by 450
Dressings for superficial and partial thickness burns
Wasiak, J., Cleland, H., Campbell, F., & Spinks, A. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002106.pub4 · Cited by 445
Is Response to Prophylactic Lithium a Familial Trait?
Grof, P., Duffy, A., Cavazzoni, P., Grof, E., Garnham, J., MacDougall, M., O'Donovan, C., & Alda, M. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n1013 · Cited by 438
Boon and Bane of Metal Ions in Medicine
Thompson, K. H., & Orvig, C. (2003) · Science · doi:10.1126/science.1083004 · Cited by 424
Self-citationMetal based drugs: from serendipity to design
Fricker, S. P. (2007) · Dalton Transactions · doi:10.1039/b705551j · Cited by 414
Szpunar, J. (2005) · The Analyst · doi:10.1039/b418265k · Cited by 406
Next-Generation Metal Anticancer Complexes: Multitargeting via Redox Modulation
Romero-Canelón, I., & Sadler, P. J. (2013) · Inorganic Chemistry · doi:10.1021/ic400835n · Cited by 396
New approaches to molecular cancer therapeutics
Collins, I., & Workman, P. (2006) · Nature Chemical Biology · doi:10.1038/nchembio840 · Cited by 391
de Bie, P., Muller, P., Wijmenga, C., & Klomp, L. W. J. (2007) · Journal of Medical Genetics · doi:10.1136/jmg.2007.052746 · Cited by 390
A Newly Identified Role for Superoxide in Inflammatory Pain
Wang, Z.-Q., Porreca, F., Cuzzocrea, S., Galen, K., Lightfoot, R., Masini, E., Muscoli, C., Mollace, V., Ndengele, M., Ischiropoulos, H., et al. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.064154 · Cited by 387
The coordination chemistry of vanadium as related to its biological functions
Rehder, D. (1999) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(98)00194-5 · Cited by 376
Platinum coordination complexes in cancer chemotherapy
Rosenberg, B. (1973) · Die Naturwissenschaften · doi:10.1007/bf00623551 · Cited by 374
Radioisotopes for the palliation of metastatic bone cancer: a systematic review
Finlay, I. G., Mason, M. D., & Shelley, M. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70206-0 · Cited by 369
Metallomics: the concept and methodology
Mounicou, S., Szpunar, J., & Lobinski, R. (2009) · Chemical Society Reviews · doi:10.1039/b713633c · Cited by 368
Principles and Recent Developments in Chelation Treatment of Metal Intoxication
Andersen, O. (1999) · Chemical Reviews · doi:10.1021/cr980453a · Cited by 364
Menendez, C., Kahigwa, E., Hirt, R., Vounatsou, P., Aponte, J. J., Font, F., Acosta, C. J., Schellenberg, D. M., Galindo, C. M., Kimario, J., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(97)04229-3 · Cited by 353
Coordination chemistry of vanadium in metallopharmaceutical candidate compounds
Thompson, K. H. (2001) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(01)00395-2 · Cited by 335
Scott, L. E., & Orvig, C. (2009) · Chemical Reviews · doi:10.1021/cr9000176 · Cited by 332
Self-citationDesign of targeting ligands in medicinal inorganic chemistry
Storr, T., Thompson, K. H., & Orvig, C. (2006) · Chemical Society Reviews · doi:10.1039/b514859f · Cited by 326
Self-citationSafety and effectiveness of long-term therapy with the oral iron chelator deferiprone
Cohen, A. R., Galanello, R., Piga, A., De Sanctis, V., & Tricta, F. (2003) · Blood · doi:10.1182/blood-2002-10-3280 · Cited by 323
Brewer, G. J., Hedera, P., Kluin, K. J., Carlson, M., Askari, F., Dick, R. B., Sitterly, J., & Fink, J. K. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.379 · Cited by 308
Concepts and models in bioinorganic chemistry
(2007) · Choice Reviews Online · doi:10.5860/choice.44-5065 · Cited by 305
Metal complexes in medicinal chemistry: new vistas and challenges in drug design
Thompson, K. H., & Orvig, C. (2006) · Dalton Trans. · doi:10.1039/b513476e · Cited by 298
Self-citationBartholomä, M. D., Louie, A. S., Valliant, J. F., & Zubieta, J. (2010) · Chemical Reviews · doi:10.1021/cr1000755 · Cited by 298
Ruthenium complexes can target determinants of tumour malignancy
Bergamo, A., & Sava, G. (2007) · Dalton Transactions · doi:10.1039/b617769g · Cited by 291
Biological Activity of Complex Ions
DWYER, F. P., GYARFAS, E. C., ROGERS, W. P., & KOCH, J. H. (1952) · Nature · doi:10.1038/170190a0 · Cited by 289
Harris, W. R., Carrano, C. J., Cooper, S. R., Sofen, S. R., Avdeef, A. E., McArdle, J. V., & Raymond, K. N. (1979) · Journal of the American Chemical Society · doi:10.1021/ja00514a037 · Cited by 289
Clinical overview on Lipoplatin™: a successful liposomal formulation of cisplatin
Boulikas, T. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903114168 · Cited by 276
Exploring biologically relevant chemical space with metal complexes
Meggers, E. (2007) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2007.05.013 · Cited by 274
The Composition of Ehrlich's Salvarsan: Resolution of a Century‐Old Debate
Lloyd, N. C., Morgan, H. W., Nicholson, B. K., & Ronimus, R. S. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200461471 · Cited by 256
Tumour targeting with radiometals for diagnosis and therapy
Ramogida, C. F., & Orvig, C. (2013) · Chemical Communications · doi:10.1039/c3cc41554f · Cited by 255
Self-citationEvolution of Tc-99m in diagnostic radiopharmaceuticals
Banerjee, S., Ambikalmajan Pillai, M. R., & Ramamoorthy, N. (2001) · Seminars in Nuclear Medicine · doi:10.1053/snuc.2001.26205 · Cited by 253
Lee, S.-M., Kim, H. J., Ha, Y.-J., Park, Y. N., Lee, S.-K., Park, Y.-B., & Yoo, K.-H. (2013) · ACS Nano · doi:10.1021/nn301215q · Cited by 250
Making Better Drugs: Decision Gates in Non-Clinical Drug Development
Pritchard, J. F., Jurima-Romet, M., Reimer, M. L. J., Mortimer, E., Rolfe, B., & Cayen, M. N. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1131 · Cited by 246
Lithium in the Treatment of Mood Disorders
Wood, A. J. J., Price, L. H., & Heninger, G. R. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409013310907 · Cited by 244
Clioquinol: Review of its Mechanisms of Action and Clinical Uses in Neurodegenerative Disorders
Bareggi, S. R., & Cornelli, U. (2012) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00231.x · Cited by 243
Handbook of Metal-Ligand Interactions in Biological Fluids
Berthon, G. (1995) · Cited by 243
Metal-based antitumour drugs in the post-genomic era: what comes next?
Sava, G., Bergamo, A., & Dyson, P. J. (2011) · Dalton Transactions · doi:10.1039/c1dt10522a · Cited by 231
Willsky, G. R., Goldfine, A. B., Kostyniak, P. J., McNeill, J. H., Yang, L. Q., Khan, H. R., & Crans, D. C. (2001) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(00)00226-9 · Cited by 205
Tetrathiomolybdate Inhibits Copper Trafficking Proteins Through Metal Cluster Formation
Alvarez, H. M., Xue, Y., Robinson, C. D., Canalizo-Hernández, M. A., Marvin, R. G., Kelly, R. A., Mondragón, A., Penner-Hahn, J. E., & O’Halloran, T. V. (2010) · Science · doi:10.1126/science.1179907 · Cited by 204
Some Biological Effects of Platinum Compounds: New Agents for the Control of Tumours
Rosenberg, B. (1971) · Platinum Metals Review · doi:10.1595/003214071x1524251 · Cited by 203
Aziz, Z., Abu, S. F., & Chong, N. J. (2012) · Burns · doi:10.1016/j.burns.2011.09.020 · Cited by 198
Casini, A., & Reedijk, J. (2012) · Chemical Science · doi:10.1039/c2sc20627g · Cited by 196
Handbook of Metal-Ligand Interactions in Biological Fluids
Flodin, N. W. (1996) · Journal of the American College of Nutrition · doi:10.1080/07315724.1996.10738027 · Cited by 186
Chen, S.-J., Zhou, G.-B., Zhang, X.-W., Mao, J.-H., de Thé, H., & Chen, Z. (2011) · Blood · doi:10.1182/blood-2010-11-283598 · Cited by 183
The antimalarial ferroquine: from bench to clinic
Biot, C., Nosten, F., Fraisse, L., Ter-Minassian, D., Khalife, J., & Dive, D. (2011) · Parasite · doi:10.1051/parasite/2011183207 · Cited by 180
Banerjee, S. R., Maresca, K. P., Francesconi, L., Valliant, J., Babich, J. W., & Zubieta, J. (2005) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2004.09.001 · Cited by 179
Berners-Price, S. J., Ronconi, L., & Sadler, P. J. (2006) · Progress in Nuclear Magnetic Resonance Spectroscopy · doi:10.1016/j.pnmrs.2006.05.002 · Cited by 176
In Vitro Antimalarial Activity of a New Organometallic Analog, Ferrocene-Chloroquine
Domarle, O., Blampain, G., Agnaniet, H., Nzadiyabi, T., Lebibi, J., Brocard, J., Maciejewski, L., Biot, C., Georges, A. J., & Millet, P. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.3.540 · Cited by 170
Photoactivatable metal complexes: from theory to applications in biotechnology and medicine
Smith, N. A., & Sadler, P. J. (2013) · Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences · doi:10.1098/rsta.2012.0519 · Cited by 170
Anticancer metal compounds in NCI's tumor-screening database: putative mode of action
Huang, R., Wallqvist, A., & Covell, D. G. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.01.001 · Cited by 169
Ueber die Einwirkung des Ammoniaks auf Platinchlorür
Peyrone, M. (1844) · Justus Liebigs Annalen der Chemie · doi:10.1002/jlac.18440510102 · Cited by 168
Salas, P. F., Herrmann, C., & Orvig, C. (2013) · Chemical Reviews · doi:10.1021/cr3001252 · Cited by 163
Self-citationRodríguez-Rodríguez, C., Telpoukhovskaia, M., & Orvig, C. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.03.008 · Cited by 151
Self-citationEmerging protein targets for metal-based pharmaceutical agents: An update
de Almeida, A., Oliveira, B. L., Correia, J. D. G., Soveral, G., & Casini, A. (2013) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2013.01.031 · Cited by 149
Challenges for Metals in Medicine: How Nanotechnology May Help To Shape the Future
Barry, N. P. E., & Sadler, P. J. (2013) · ACS Nano · doi:10.1021/nn403220e · Cited by 148
Stoffwechselprodukte von Actinomyceten. 27. Mitteilung. Über die Konstitution von Ferrioxamin B
Bickel, H., Hall, G. E., KELLER‐SCHIERLEIN, W., Prelog, V., Vischer, E., & Wettstein, A. (1960) · Helvetica Chimica Acta · doi:10.1002/hlca.19600430732 · Cited by 143
Hájek, T., Bauer, M., Simhandl, C., RYBAKOWSKI, J. K., O’Donovan, C., Pfennig, A., König, B., Suwalska, A., Yücel, K., Uher, R., et al. (2013) · Psychological Medicine · doi:10.1017/s0033291713001165 · Cited by 135
Target Validation: Linking Target and Chemical Properties to Desired Product Profile
Wyatt, P. G., Gilbert, I. H., Read, K. D., & Fairlamb, A. H. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611795429185 · Cited by 131
The prevalence of metal-based drugs as therapeutic or diagnostic agents: beyond platinum
Gaynor, D., & Griffith, D. M. (2012) · Dalton Transactions · doi:10.1039/c2dt31601c · Cited by 127
Metal imaging in neurodegenerative diseases
Bourassa, M. W., & Miller, L. M. (2012) · Metallomics · doi:10.1039/c2mt20052j · Cited by 126
Clercq, E. D. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.08.009 · Cited by 125
Albert, A. (1985) · Springer eBooks · doi:10.1007/978-94-009-4846-4 · Cited by 125
A History of the Use of Arsenicals in Man
Jolliffe, D. (1993) · Journal of the Royal Society of Medicine · doi:10.1177/014107689308600515 · Cited by 118
Smith, S. M., Cousins, G., Clyne, B., Allwright, S., & O’Dowd, T. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004910.pub3 · Cited by 118
Metal Complexes for Therapy and Diagnosis of Drug Resistance
Sharma, V., & Piwnica-Worms, D. R. (1999) · Chemical Reviews · doi:10.1021/cr980429x · Cited by 115
Werner coordination chemistry and neurodegeneration
Telpoukhovskaia, M. A., & Orvig, C. (2012) · Chemical Society Reviews · doi:10.1039/c2cs35236b · Cited by 112
Self-citationDuffy, A. C., Alda, M., Kutcher, S., Cavazzoni, P. A., Robertson, C. A., Grof, E., & Grof, P. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n1213 · Cited by 111
Chemical and Biological Considerations in the Treatment of Metal Intoxications by Chelating Agents
Andersen, O. (2004) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557043487583 · Cited by 111
Superoxide: a key player in hypertension
Cuzzocrea, S., Mazzon, E., Dugo, L., Paola, R. D., Caputi, A. P., & Salvemini, D. (2004) · The FASEB Journal · doi:10.1096/fj.03-0428com · Cited by 106
Inorganic Pharmacology of Lithium
Birch, N. J. (1999) · Chemical Reviews · doi:10.1021/cr9804240 · Cited by 104
Lehman, A. J., Esdaile, J. M., Klinkhoff, A. V., Grant, E., Fitzgerald, A. A., Canvin, J., & The METGO Study Group (2005) · Arthritis & Rheumatism · doi:10.1002/art.21018 · Cited by 103
Equilibrium constants for the binding of aluminum to human serum transferrin
Harris, W. R., & Sheldon, J. (1990) · Inorganic Chemistry · doi:10.1021/ic00326a024 · Cited by 102
Comparison of liposomal cisplatin versus cisplatin in non-squamous cell non-small-cell lung cancer
Stathopoulos, G. P., Antoniou, D., Dimitroulis, J., Stathopoulos, J., Marosis, K., & Michalopoulou, P. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-011-1572-5 · Cited by 102
The Cost of Developing Imaging Agents for Routine Clinical Use
Nunn, A. D. (2006) · Investigative Radiology · doi:10.1097/01.rli.0000191370.52737.75 · Cited by 101
Arsenic and lead induced free radical generation and their reversibility following chelation.
Flora, S. J. S., Flora, G., Saxena, G., & Mishra, M. (2007) · PubMed · Cited by 101
Sava, G., Jaouen, G., Hillard, E. A., & Bergamo, A. (2012) · Dalton Transactions · doi:10.1039/c2dt30075c · Cited by 97
Nanoparticle Encapsulation of Mitaplatin and the Effect Thereof onIn VivoProperties
Johnstone, T. C., Kulak, N., Pridgen, E. M., Farokhzad, O. C., Langer, R., & Lippard, S. J. (2013) · ACS Nano · doi:10.1021/nn401905g · Cited by 96
Crystal Structure of the PIM2 Kinase in Complex with an Organoruthenium Inhibitor
Bullock, A. N., Russo, S., Amos, A. L., Pagano, N., Bregman, H. S., Debreczeni, J. E., Lee, W. H., von Delft, F., Meggers, E., & Knapp, S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007112 · Cited by 96
Novel and emerging approaches for the delivery of metallo-drugs
Sánchez-Cano, C., & Hannon, M. J. (2009) · Dalton Transactions · doi:10.1039/b912708a · Cited by 93
Prodrugs - An Efficient Way to Breach Delivery and Targeting Barriers
Huttunen, K. M., & Rautio, J. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611797183230 · Cited by 86
Pharmacogenetics of Lithium Response in Bipolar Disorder
McCarthy, M. J., Leckband, S. G., & Kelsoe, J. R. (2010) · Pharmacogenomics · doi:10.2217/pgs.10.127 · Cited by 80
Eickhoff, T. C., & Myers, M. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00163-9 · Cited by 76
Sankararamakrishnan, R., Verma, S. K., & Verma, S. K. (2004) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.20265 · Cited by 75
Wecksler, S. R., Mikhailovsky, A. A., Korystov, D., Buller, F., Kannan, R., Tan, L., & Ford, P. C. (2006) · Inorganic Chemistry · doi:10.1021/ic0607336 · Cited by 72
The Bioinorganic Chemistry of Chromium
Vincent, J. B. (2012) · Wiley eBooks · doi:10.1002/9781118458891 · Cited by 72
In vitroandin vivoantiproliferative and trypanocidal activities of ruthenium NO donors
Silva, J. J. N., Osakabe, A. L., Pavanelli, W. R., Silva, J. S., & Franco, D. W. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707363 · Cited by 71
Friedel, F. C., Lieb, D., & Ivanović‐Burmazović, I. (2011) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2011.12.008 · Cited by 70
Ruthenium-nitrite complex as pro-drug releases NO in a tissue and enzyme-dependent way
Pereira, A. D. C., Ford, P. C., da Silva, R. S., & Bendhack, L. M. (2011) · Nitric Oxide · doi:10.1016/j.niox.2011.03.001 · Cited by 68
Claret, M., Corominola, H., Canals, I., Saura, J., Barceló-Batllori, S., Guinovart, J. J., & Gomis, R. (2005) · Endocrinology · doi:10.1210/en.2005-0385 · Cited by 60
Exploring the mechanisms of metalbased pharmacological agents via an integrated approach
Casini, A. (2011) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2011.12.007 · Cited by 56
Gold‐Based Therapeutic Agents: A New Perspective
Berners‐Price, S. J. (2011) · Wiley eBooks · doi:10.1002/9783527633104.ch7 · Cited by 54
Inert ruthenium half-sandwich complexes with anticancer activity
Meggers, E., Atilla‐Gokcumen, G. E., Gründler, K., Frias, C., & Prokop, A. (2009) · Dalton Transactions · doi:10.1039/b917792b · Cited by 54
Charest, G., Sanche, L., Fortin, D., Mathieu, D., & Paquette, B. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1238-8 · Cited by 54
Pouladi, M. A., Brillaud, E., Xie, Y., Conforti, P., Graham, R. K., Ehrnhoefer, D. E., Franciosi, S., Zhang, W., Poucheret, P., Compte, E., et al. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.06.026 · Cited by 53
Metallomics: An integrated science for metals in biology and medicine
Sun, H., & Chai, Z. (2010) · Annual Reports Section A (Inorganic Chemistry) · doi:10.1039/b920672h · Cited by 39
Proof‐of‐concept trial on the efficacy of sodium tungstate in human obesity
Hanzu, F. A., Gomis, R., Coves, M. J., Viaplana, J., Palomo, M., Andreu, A., Szpunar, J., & Vidal, J. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01293.x · Cited by 39
Photodynamic therapy for prostate cancer-an emerging approach for organ-confined disease
Moore, C. M., Emberton, M., & Bown, S. G. (2011) · Lasers in Surgery and Medicine · doi:10.1002/lsm.21104 · Cited by 35
Barriers to Clinical Translation with Diagnostic Drugs
Josephson, L., & Rudin, M. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.107615 · Cited by 27
Synthetic and Natural Products as Iron Chelators
Sharpe, P. C., Richardson, D. R., Kalinowski, D. S., & Bernhardt, P. V. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611794785163 · Cited by 26
Chast, F. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374194-3.00001-9 · Cited by 23
Bytzek, A. K., & Hartinger, C. G. (2012) · Electrophoresis · doi:10.1002/elps.201100402 · Cited by 23
Garnier, N. M., Petruccelli, L. A., Molina, M. F., Kourelis, M., Kwan, S., Diaz, Z., Schipper, H. M., Gupta, A., Rincon, S. V. D., Mann, K. K., et al. (2013) · Leukemia · doi:10.1038/leu.2013.54 · Cited by 18
Nejrup, K., Olivarius, N. D. F., Jacobsen, J. L., & Siersma, V. (2008) · Clinical Rheumatology · doi:10.1007/s10067-008-0918-9 · Cited by 18
Osmium tetroxide, used in the treatment of arthritic joints, is a fast mimic of superoxide dismutase
Goldstein, S., Czapski, G., & Heller, A. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.10.027 · Cited by 17
Badrick, A. C., & Jones, C. E. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611794785181 · Cited by 16
Structural approaches to probing metal interaction with proteins
Parker, L. J., Ascher, D. B., Gao, C., Miles, L. A., Harris, H. H., & Parker, M. W. (2012) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2012.02.015 · Cited by 14
Testing the mettle of PBT2 for Alzheimer's disease
Relkin, N. R. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70168-6 · Cited by 12
Iron Deficiency and Severe Plasmodium falciparum Malaria
Awah, N. W., & Kaneko, A. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis020 · Cited by 6
Cited by
Encyclopedia of Inorganic and Bioinorganic Chemistry
(2011) · Wiley eBooks · doi:10.1002/9781119951438 · Cited by 1,585
Platinum-based drugs for cancer therapy and anti-tumor strategies
Zhang, C., Xu, C., Gao, X., & Yao, Q. (2022) · Theranostics · doi:10.7150/thno.69424 · Cited by 1,018
Stimuli-Responsive Therapeutic Metallodrugs
Wang, X., Wang, X., Jin, S., Muhammad, N., & Guo, Z. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00209 · Cited by 649
Toward Multi-Targeted Platinum and Ruthenium Drugs—A New Paradigm in Cancer Drug Treatment Regimens?
Kenny, R. G., & Marmion, C. J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00271 · Cited by 636
Metal complexes as a promising source for new antibiotics
Frei, A., Zuegg, J., Elliott, A. G., Baker, M., Braese, S., Brown, C., Chen, F., G. Dowson, C., Dujardin, G., Jung, N., et al. (2020) · Chemical Science · doi:10.1039/c9sc06460e · Cited by 543
Metadata
- Authors
- Mjos, K. D., & Orvig, C.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2014-01-23
- Volume
- 114
- Issue
- 8
- Pages
- 4540-4563
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W2334138351
- Cited by
- 1,289
- References
- 154
- FWCI
- 8.37
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.